These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37569485)

  • 21. A Series of Spiropyrimidinetriones that Enhances DNA Cleavage Mediated by
    Byl JAW; Mueller R; Bax B; Basarab GS; Chibale K; Osheroff N
    ACS Infect Dis; 2023 Mar; 9(3):706-715. PubMed ID: 36802491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae.
    Alm RA; Lahiri SD; Kutschke A; Otterson LG; McLaughlin RE; Whiteaker JD; Lewis LA; Su X; Huband MD; Gardner H; Mueller JP
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1478-86. PubMed ID: 25534723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria.
    Lapointe G; Skepper CK; Holder LM; Armstrong D; Bellamacina C; Blais J; Bussiere D; Bian J; Cepura C; Chan H; Dean CR; De Pascale G; Dhumale B; Fisher LM; Fulsunder M; Kantariya B; Kim J; King S; Kossy L; Kulkarni U; Lakshman J; Leeds JA; Ling X; Lvov A; Ma S; Malekar S; McKenney D; Mergo W; Metzger L; Mhaske K; Moser HE; Mostafavi M; Namballa S; Noeske J; Osborne C; Patel A; Patel D; Patel T; Piechon P; Polyakov V; Prajapati K; Prosen KR; Reck F; Richie DL; Sanderson MR; Satasia S; Savani B; Selvarajah J; Sethuraman V; Shu W; Tashiro K; Thompson KV; Vaarla K; Vala L; Veselkov DA; Vo J; Vora B; Wagner T; Wedel L; Williams SL; Yendluri S; Yue Q; Yifru A; Zhang Y; Rivkin A
    J Med Chem; 2021 May; 64(9):6329-6357. PubMed ID: 33929852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based design of novel combinatorially generated NBTIs as potential DNA gyrase inhibitors against various Staphylococcus aureus mutant strains.
    Kolaric A; Minovski N
    Mol Biosyst; 2017 Jun; 13(7):1406-1420. PubMed ID: 28590495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between Gepotidacin and
    Oviatt AA; Gibson EG; Huang J; Mattern K; Neuman KC; Chan PF; Osheroff N
    ACS Infect Dis; 2024 Apr; 10(4):1137-1151. PubMed ID: 38606465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.
    Hofny HA; Mohamed MFA; Gomaa HAM; Abdel-Aziz SA; Youssif BGM; El-Koussi NA; Aboraia AS
    Bioorg Chem; 2021 Jul; 112():104920. PubMed ID: 33910078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
    Gjorgjieva M; Tomašič T; Barančokova M; Katsamakas S; Ilaš J; Tammela P; Peterlin Mašič L; Kikelj D
    J Med Chem; 2016 Oct; 59(19):8941-8954. PubMed ID: 27541007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site.
    Franco-Ulloa S; La Sala G; Miscione GP; De Vivo M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of
    Pisano L; Giovannuzzi S; Supuran CT
    Expert Opin Ther Pat; 2024 Jun; 34(6):511-524. PubMed ID: 38856987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors.
    D'Atanasio N; Capezzone de Joannon A; Di Sante L; Mangano G; Ombrato R; Vitiello M; Bartella C; Magarò G; Prati F; Milanese C; Vignaroli C; Di Giorgio FP; Tongiani S
    PLoS One; 2020; 15(2):e0228509. PubMed ID: 32074119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 2.8 Å Structure of Zoliflodacin in a DNA Cleavage Complex with
    Morgan H; Lipka-Lloyd M; Warren AJ; Hughes N; Holmes J; Burton NP; Mahenthiralingam E; Bax BD
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amide containing NBTI antibacterials with reduced hERG inhibition, retained antimicrobial activity against gram-positive bacteria and in vivo efficacy.
    Kokot M; Weiss M; Zdovc I; Senerovic L; Radakovic N; Anderluh M; Minovski N; Hrast M
    Eur J Med Chem; 2023 Mar; 250():115160. PubMed ID: 36753879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion.
    Bax BD; Murshudov G; Maxwell A; Germe T
    J Mol Biol; 2019 Aug; 431(18):3427-3449. PubMed ID: 31301408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
    Metwally NH; Abdallah SO; Mohsen MMA
    Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into the mechanism of inhibition of novel bacterial topoisomerase inhibitors from characterization of resistant mutants of Staphylococcus aureus.
    Lahiri SD; Kutschke A; McCormack K; Alm RA
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5278-87. PubMed ID: 26077256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-generation 4,5,6,7-tetrahydrobenzo[
    Lamut A; Skok Ž; Barančoková M; Gutierrez LJ; Cruz CD; Tammela P; Draskovits G; Szili PÉ; Nyerges Á; Pál C; Molek P; Bratkovič T; Ilaš J; Zidar N; Zega A; Enriz RD; Kikelj D; Tomašič T
    Future Med Chem; 2020 Feb; 12(4):277-297. PubMed ID: 32043377
    [No Abstract]   [Full Text] [Related]  

  • 38. Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs).
    Kolarič A; Anderluh M; Minovski N
    J Med Chem; 2020 Jun; 63(11):5664-5674. PubMed ID: 32027491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities.
    Fisher LM; Pan XS
    Methods Mol Med; 2008; 142():11-23. PubMed ID: 18437302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
    Tiz DB; Skok Ž; Durcik M; Tomašič T; Mašič LP; Ilaš J; Zega A; Draskovits G; Révész T; Nyerges Á; Pál C; Cruz CD; Tammela P; Žigon D; Kikelj D; Zidar N
    Eur J Med Chem; 2019 Apr; 167():269-290. PubMed ID: 30776691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.